Blog Archives

Roche’s Rituxan Cures Rare Skin-Blistering Disease in Study

Roche Holding AG (ROG)’s top-selling drug Rituxan effectively cured most cases of a rare and deadly skin disease in a patient study that suggests the medicine may replace steroids as the standard treatment. In a trial among 22 people with

Tagged with: , , , , , , , ,
Posted in Around the Globe, News and Information, Treatment and Medication

Oral aphthosis: management gaps and recent advances.

Introduction: Though oral aphthosis is common, it has a significant impact on the quality of life in the patients. It is the most common oral ulcerative condition encountered in clinical practice. This study describes the characteristics and patterns of oral

Tagged with: , ,
Posted in Around the Globe, News and Information
JOIN TODAY!
The P/P Registry has been approved by the Western Institutional Review Board (WIRB) and is actively enrolling participants.

ENGLISH VERSION

SPANISH VERSION